Idiopathic and familial forms of pulmonary arterial hypertension (PAH) occur more frequently in women than men. However, the reason for this remains unknown. Both the calcium binding protein S100A4/Mts1 (Mts1) and its endogenous receptor (receptor for advanced glycosylation end products; RAGE) have been implicated in the development of PAH. We wished to investigate if the Mts1/RAGE pathway may play a role in the gender bias associated with PAH
Pulmonary arterial hypertension (PAH) affects more women than men, although affected females tend to...
The proliferative endothelial and smooth muscle cell phenotype, inflammation, and pulmonary vascular...
Rationale: Idiopathic pulmonary arterial hypertension (PAH) is a terminal pulmonary vascular disease...
Idiopathic and familial forms of pulmonary arterial hypertension (PAH) occur more frequently in wome...
Rationale: Major pulmonary arterial hypertension (PAH) registries report a greater incidence of PAH ...
Chronic hypoxia typically elicits pulmonary hypertension (PH) in mice with a male-dominant phenotype...
Pulmonary arterial hypertension (PAH) is up to threefold more prevalent in women than men. Female mi...
Pulmonary arterial hypertension (PAH) is a progressive disease in which increased pulmonary arterial...
The estrogen paradox in pulmonary arterial hypertension (PAH) refers to observations that while th...
The receptor for advanced glycation endproducts (RAGE) is a 35-kDa polypeptide of the immunogloblin ...
Pulmonary hypertension (PH) is a disease with high morbidity and mortality. The prevalence of idiopa...
Rationale: Females are predisposed to pulmonary arterial hypertension (PAH); evidence suggests that ...
Pulmonary arterial hypertension (PAH) is a complex and devastating disease with a poor long-term pro...
Pulmonary arterial hypertension (PAH) is a sexually dimorphic disease with female predominance. This...
Pulmonary arterial hypertension is a rare but terminal pulmonary vascular disease characterized by e...
Pulmonary arterial hypertension (PAH) affects more women than men, although affected females tend to...
The proliferative endothelial and smooth muscle cell phenotype, inflammation, and pulmonary vascular...
Rationale: Idiopathic pulmonary arterial hypertension (PAH) is a terminal pulmonary vascular disease...
Idiopathic and familial forms of pulmonary arterial hypertension (PAH) occur more frequently in wome...
Rationale: Major pulmonary arterial hypertension (PAH) registries report a greater incidence of PAH ...
Chronic hypoxia typically elicits pulmonary hypertension (PH) in mice with a male-dominant phenotype...
Pulmonary arterial hypertension (PAH) is up to threefold more prevalent in women than men. Female mi...
Pulmonary arterial hypertension (PAH) is a progressive disease in which increased pulmonary arterial...
The estrogen paradox in pulmonary arterial hypertension (PAH) refers to observations that while th...
The receptor for advanced glycation endproducts (RAGE) is a 35-kDa polypeptide of the immunogloblin ...
Pulmonary hypertension (PH) is a disease with high morbidity and mortality. The prevalence of idiopa...
Rationale: Females are predisposed to pulmonary arterial hypertension (PAH); evidence suggests that ...
Pulmonary arterial hypertension (PAH) is a complex and devastating disease with a poor long-term pro...
Pulmonary arterial hypertension (PAH) is a sexually dimorphic disease with female predominance. This...
Pulmonary arterial hypertension is a rare but terminal pulmonary vascular disease characterized by e...
Pulmonary arterial hypertension (PAH) affects more women than men, although affected females tend to...
The proliferative endothelial and smooth muscle cell phenotype, inflammation, and pulmonary vascular...
Rationale: Idiopathic pulmonary arterial hypertension (PAH) is a terminal pulmonary vascular disease...